🇺🇸 FDA
Patent

US 11325978

Compositions and methods for treating beta-globinopathies

granted A61KA61K31/713A61K9/0019

Quick answer

US patent 11325978 (Compositions and methods for treating beta-globinopathies) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/713, A61K9/0019, A61K9/0053, A61K9/08